This website has been commissioned by Ipsen Pharmaceuticals Ltd. and is intended for an Irish audience. If you are not a Healthcare Professional, please click here.
Adverse event reporting information is available at the bottom of this webpage.

Spot the Signs of Neuroendocrine Tumours (NETs)

Neuroendocrine Tumours (NETs) File
1 pages

NETs can be commonly misdiagnosed, and early recognition can make a real difference. This fact sheet highlights the causes, symptoms, and clinical features of NETs to support timely diagnosis and patient care.

SOM-IE-000809 | August 2026

Spot the Signs of Neuroendocrine Tumours (NETs)
Explore more Neuroendocrine Tumours (NETs) Resources

Explore more Neuroendocrine Tumours (NETs) Resources

Browse

To access relevant information about Neuroendocrine Tumours (NETs), please choose one of the following options:

Adverse events should be reported.
Reporting forms and information can be found at www.hpra.ie or e-mail medsafety@hpra.ie.
The HPRA can also be contacted on +353 16764971. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256.

Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly to the HPRA. Reporting forms and information can be found at www.hpra.ie or email medsafety@hpra.ie. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256. By reporting side effects, you can help provide more information on the safety of this medicine.